mutations provided The reality that, as stated beneath, CLL therapy is based about the existence or absence of these mutations. The present consensus is that, other than clonal mutations, subclonal mutations which has a variant allelic frequency ranging from 5 to ten% (and therefore under the edge of detection by conventional molecular tactics) is